Last €0.17 EUR
Change Today 0.00 / 0.00%
Volume 0.0
LJHB On Other Exchanges
Symbol
Exchange
Hong Kong
Berlin
OTC US
As of 4:00 PM 10/16/14 All times are local (Market data is delayed by at least 15 minutes).

lijun intl pharmacetl hldg (LJHB) Snapshot

Open
--
Previous Close
€0.17
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
3.0B
EX-Date
09/16/14
P/E TM
--
Dividend
€0.04
Dividend Yield
4.63%
Current Stock Chart for LIJUN INTL PHARMACETL HLDG (LJHB)

Related News

No related news articles were found.

lijun intl pharmacetl hldg (LJHB) Related Businessweek News

No Related Businessweek News Found

lijun intl pharmacetl hldg (LJHB) Details

Lijun International Pharmaceutical (Holding) Co., Ltd., an investment holding company, is engaged in the research, development, manufacture, and sale of a range of pharmaceutical products to hospitals and distributors primarily in Mainland China. The company operates through two segments, Intravenous Infusion Solution and Others; and Antibiotics and Others. It offers antibiotics, intravenous infusion solutions, non-antibiotics finished medicines, bulk pharmaceuticals, and OTC and healthcare products. The company is also involved in researching, developing, and consulting pharmaceutical technology; and providing logistics services for pharmaceutical products. It offers intravenous infusion solutions under the Shimen brand name. The company is headquartered in Wanchai, Hong Kong.

4,700 Employees
Last Reported Date: 09/19/14

lijun intl pharmacetl hldg (LJHB) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $7.4M
Executive Director
Total Annual Compensation: $1.2M
Compensation as of Fiscal Year 2013.

lijun intl pharmacetl hldg (LJHB) Key Developments

Lijun International Pharmaceutical (Holding) Co., Ltd. Announces Executive Changes

The board of the directors of Lijun International Pharmaceutical (Holding) Co. Ltd. announced that Mr. Su Xuejun has been appointed as the executive director of the company with effect from 15 December 2014 and Mr. Duan Wei has been resigned as the executive director of the company with effect from 15 December 2014. Mr. Su, aged 46, was appointed as the executive director of the company. He is currently the executive director, deputy chairman and deputy general manager of Shijiazhuang No.4 Pharmaceutical Co. Ltd., responsible for the company's overall marketing and management. Mr. Su joined Shijiazhuang City No.1 Pharmaceutical Factory as assistant to factory manager in 1990. And afterwards he served as deputy general manager of a subsidiary of the Shijiazhuang Pharmaceutical Group selling preparations. Since January 2002, Mr. Su acts as deputy general manager of Shijiazhuang No.4 Pharmaceutical Co. Ltd. Since January 2007, Mr. Su acts as executive director of Shijiazhuang No.4 Pharmaceutical Co. Ltd. and New Orient Investments Pharmaceutical Holding (Hong Kong) Limited. Since July 2013, Mr. Su acts as deputy chairman of Shijiazhuang No.4 Pharmaceutical Co. Ltd. The board of the company announced that Mr. Duan has resigned as an executive director of the company with effect from 15 December 2014 in order to devote more time to his other business engagements.

Lijun International Pharmaceutical (Holding) Co Ltd., Special/Extraordinary Shareholders Meeting, Oct 10, 2014

Lijun International Pharmaceutical (Holding) Co Ltd., Special/Extraordinary Shareholders Meeting, Oct 10, 2014., at 14:00 China Standard Time. Location: 2101-02, 21st Floor. Agenda: To approve the disposal, the entry into of the disposal agreement by the company and the performance of the company's obligations under the disposal agreement; to authorize the directors of the company to implement the disposal agreement and all the transactions contemplated there under; and to approve the declaration of the special dividend as mentioned in the circular.

Lijun International Pharmaceutical (Holding) Co Ltd. Presents at Bank of America Merrill Lynch China Conference 2014, Nov-03-2014

Lijun International Pharmaceutical (Holding) Co Ltd. Presents at Bank of America Merrill Lynch China Conference 2014, Nov-03-2014 . Venue: JW Marriott Beijing (Chaoyang), Beijing, China.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LJHB:GR €0.17 EUR 0.00

LJHB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LJHB.
View Industry Companies
 

Industry Analysis

LJHB

Industry Average

Valuation LJHB Industry Range
Price/Earnings 22.1x
Price/Sales 3.7x
Price/Book 3.4x
Price/Cash Flow 22.3x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIJUN INTL PHARMACETL HLDG, please visit www.lijun.com.hk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.